South & Central America Bioreactors Market Forecast to 2030

South & Central America Bioreactors Market Forecast to 2030

South & Central America Bioreactors Market Forecast to 2030 – Regional Analysis – by Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), and End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization)

Send Enquiry
Item ID: BMIRE00030246 Category: Tag:

$2,485 – $3,885

Description

The South & Central America bioreactors market was valued at US$ 246.23 million in 2022 and is expected to reach US$ 388.31 million by 2030; it is estimated to grow at a CAGR of 5.9% from 2022 to 2030.

Rapid Growth of Pharmaceutical and Biotechnology Industry Fuels South & Central America Bioreactors Market

In recent years, the pharmaceutical industry has been growing at an unprecedented pace. Big pharmaceutical companies and contract research organizations (CROs) are coming up with new medicines and therapy forms to treat a wide range of indications. The biopharmaceuticals market is increasing. The strong demand for biologics and biosimilars has driven the growth of the industry. The biopharmaceutical industry is one of the most significant contributors to the economy. With 105 events approved, Brazil is the world’s second-largest producer of biotech crops. According to FAS Brasilia, 68 million hectares will be planted with GE traits during the 2022–2023 agricultural season. Besides growing economies, rapid growth is witnessed in the research environment in emerging economies such as Brazil, China, and India. Factors such as increasing biologics approval, growing biosimilar pipeline, and rising investment in research activities are facilitating the growth of the industry.

Biopharmaceutical research activities are gaining pace in emerging economies such as Brazil, China, and India and offering lucrative opportunities to the market. Apart from this, increasing approvals in gene and cell therapies are favoring market growth. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency and Strimvelis- treating ADA-Severe Combined Immuno Deficiency. Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioreactors market globally.

South & Central America Bioreactors Market Overview

Brazil has manufacturing plants for a large number of pharmaceutical companies. In addition, many foreign companies often collaborate and partner with Brazilian laboratories and local companies for the development of biotechnology-based medicines. The collaborative efforts are expected to yield the development of novel products in Brazil during the forecast year.

The majority of research is conducted in universities and other federal state institutions in Brazil. As per the DWIH São Paulo, biotechnology research is one of the first-tier priorities in Brazil. Many studies are being carried out in research centers in Brazil to develop advanced bioreactors for their various applications in the biotechnology sector. For instance, in an article published by MDPI in August 2022, a study was conducted by research departments of universities in Brazil. The study presented a mathematical model that was developed to describe and analyze the bioreactor’s dynamic behavior during fermentation, taking into account temperature control via refrigerant fluid flow through the reactor jacket.

Similarly, another study, “Development of a Novel Pilot-Scale Tray Bioreactor for Solid-State Fermentation Aiming at Process Intensification,” was carried out by researchers in Brazilian universities in November 2023. These research and development activities are anticipated to boost the bioreactor market in Brazil.

South & Central America Bioreactors Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bioreactors Market Segmentation

The South & Central America bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the South & Central America bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.

In terms of application, the South & Central America bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.

By technology, the South & Central America bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.

Based on end user, the South & Central America bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.

Based on country, the South & Central America bioreactors market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioreactors market share in 2022.

General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc are some of the leading players operating in the South & Central America bioreactors market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 5.9% CAGR, South & Central America Bioreactors Market is Speculated to be Worth US$ 388.31 Million by 2030, says the Research Team

According to the Research Team’ research, the South & Central America bioreactors market was valued at US$ 246.23 million in 2022 and is expected to reach US$ 388.31 million by 2030, registering a CAGR of 5.9% from 2022 to 2030. Rising demand for personalized medicine and technological advancements in bioreactors are among the critical factors attributed to the South & Central America bioreactors market expansion.

The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle diseases such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products, many of them for a relatively small number of patients. A fundamentally different approach to the production and delivery of biological products may be required.

Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The rising prevalence of a number of chronic diseases has increased the demand for biologics, drugs for orphan diseases, and personalized medicines. For instance, in 2019, the FDA approved 12 personalized medications to address the root causes of disease and further integrate precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program will focus on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. The rising demand for personalized medicine is anticipated to offer significant growth opportunities to the players operating in the bioreactors market during the forecast period.

On the contrary, stringent regulatory framework hurdles the growth of South & Central America bioreactors market.

Based on scale, the South & Central America bioreactors market is categorized into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held 48.4% share of South & Central America bioreactors market in 2022, amassing US$ 119.19 million. It is projected to garner US$ 185.69 million by 2030 to expand at 5.7% CAGR during 2022-2030.

In terms of application, the South & Central America bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held 48.7% share of South & Central America bioreactors market in 2022, amassing US$ 119.84 million. It is projected to garner US$ 185.72 million by 2030 to expand at 5.6% CAGR during 2022-2030.

By technology, the South & Central America bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held 62.1% share of South & Central America bioreactors market in 2022, amassing US$ 152.81 million. It is projected to garner US$ 230.14 million by 2030 to expand at 5.3% CAGR during 2022-2030.

Based on end user, the South & Central America bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held 60.4% share of South & Central America bioreactors market in 2022, amassing US$ 148.67 million. It is projected to garner US$ 246.73 million by 2030 to expand at 6.5% CAGR during 2022-2030.

Based on country, the South & Central America bioreactors market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 43.7% share of South & Central America bioreactors market in 2022. It was assessed at US$ 107.50 million in 2022 and is likely to hit US$ 177.26 million by 2030, exhibiting a CAGR of 6.5% during 2022-2030.

Key players operating in the South & Central America bioreactors market are General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc, among others.

In July 2023, PBS Biotech Inc and Stemcell Technologies Inc have entered into a supply arrangement that will enable researchers to access PBS-MINI Bioreactors. Through this partnership, PBS will support researchers who wish to grow their cultures of human pluripotent stem cells, or hPSCs, which are essential for drug discovery, disease modeling, future cell-based therapeutics, and pharmaceutical applications. In August 2023, Emerson collaborated with life science group Sartorius to natively integrate Sartorius’s Biostat STR Generation 3 family of bioreactors with Emerson’s DeltaVTM distributed control system (DCS). DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provides a foundation for semi-autonomous operations and up to 80% less integration time.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioreactors market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioreactors market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioreactors market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioreactors Market – Key Industry Dynamics
4.1 Bioreactors Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Adoption of Single-Use Bioreactors
4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:
5. Bioreactors Market – South & Central America Market Analysis
5.1 Overview
5.2 Bioreactors Market Revenue (US$ Million), 2020 – 2030
6. South & Central America Bioreactors Market Analysis – Scale
6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
6.3.1 Overview
6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
6.4.1 Overview
6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Production
6.5.1 Overview
6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Bioreactors Market Analysis – Application
7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
7.3.1 Overview
7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
7.4.1 Overview
7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Bioreactors Market Analysis – Technology
8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
8.3.1 Overview
8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
8.4.1 Overview
8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Bioreactors Market Analysis – End User
9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
9.3.1 Overview
9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
9.4.1 Overview
9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
9.5.1 Overview
9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Bioreactors Market – by Country Analysis
10.1 South & Central America: Bioreactors Market
10.1.1 South & Central America Bioreactors Market Revenue and Forecasts and Analysis – By Country
10.1.1.1 Brazil
10.1.1.2 Overview
10.1.1.3 Brazil: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Brazil Bioreactors Market Breakdown by Scale
10.1.1.3.2 Brazil Bioreactors Market Breakdown by Application
10.1.1.3.3 Brazil Bioreactors Market Breakdown by Technology
10.1.1.3.4 Brazil Bioreactors Market Breakdown by End User
10.1.1.4 Argentina
10.1.1.5 Overview
10.1.1.6 Argentina: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Argentina Bioreactors Market Breakdown by Scale
10.1.1.6.2 Argentina Bioreactors Market Breakdown by Application
10.1.1.6.3 Argentina Bioreactors Market Breakdown by Technology
10.1.1.6.4 Argentina Bioreactors Market Breakdown by End User
10.1.1.7 Rest of South & Central America
10.1.1.8 Overview
10.1.1.9 Rest of South & Central America: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.9.1 Rest of South & Central America Bioreactors Market Breakdown by Scale
10.1.1.9.2 Rest of South & Central America Bioreactors Market Breakdown by Application
10.1.1.9.3 Rest of South & Central America Bioreactors Market Breakdown by Technology
10.1.1.9.4 Rest of South & Central America Bioreactors Market Breakdown by End User
11. Bioreactors Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 PBS Biotech Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 General Electric Co
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sartorius AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pall Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Solaris Biotechnology SRL
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Bioreactors Market Segmentation
Table 2. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Scale
Table 3. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Application
Table 4. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Technology
Table 5. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 6. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Scale
Table 7. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Application
Table 8. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Technology
Table 9. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 10. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Scale
Table 11. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Application
Table 12. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Technology
Table 13. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 14. Recent Inorganic Growth Strategies in the Bioreactors Market
Table 15. Recent Organic Growth Strategies in the Bioreactors Market
Table 16. Glossary of Terms, Bioreactors Market
 

LIST OF FIGURES

Figure 1. Bioreactors Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Bioreactors Market Revenue (US$ Million), 2020 – 2030
Figure 4. Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
Figure 5. Lab-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Pilot-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Full-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
Figure 9. Microbial Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Cell Culture Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. Fed-Batch Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Perfusion Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16. Biopharma Manufacturers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 17. Research and Development Organizations Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Contract Manufacturing Organization Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. South & Central America: Bioreactors Market, By Key Country – Revenue (2022) (US$ Million)
Figure 20. South & Central America Bioreactors Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 21. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 22. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 23. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 24. Growth Strategies in the Bioreactors Market

The List of Companies – South & Central America Bioreactors Market

1. General Electric Co
2. Merck KGaA
3. Pall Corp
4. PBS Biotech Inc
5. Sartorius AG
6. Solaris Biotechnology SRL
7. Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “South & Central America Bioreactors Market Forecast to 2030”